Carlos Malvestutto MD MPH, FIDSA
HIV/AIDS Medicine
Professor of Medicine
Join to View Full Profile
700 Childrens DrColumbus, OH 43205
Phone+1 614-722-4450
Dr. Malvestutto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineFellowship, Infectious Disease, 2008 - 2010
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2005 - 2008
Ponce Health Sciences University School of MedicineClass of 2005
Johns Hopkins School of Hygiene and Public HealthMPH, Public Health, 1998 - 2000- Yale UniversityBS, Biology, 1992 - 1996
Certifications & Licensure
OH State Medical License 2014 - 2026
TX State Medical License 2024 - 2026
NY State Medical License 2010 - 2015
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Clinical Trials
- Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living with HIV on Suppressive Antiretroviral Therapy Start of enrollment: 2021 Sep 30
- Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults Start of enrollment: 2015 Mar 26
- ACTIV-2: A Study for Outpatients With COVID-19 Start of enrollment: 2020 Aug 19
Publications & Presentations
PubMed
- Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV.Steven K Grinspoon, Maya Watanabe, Heather J Ribaudo, Gerald S Bloomfield, Carl J Fichtenbaum
Clinical Infectious Diseases. 2025-04-25 - 1 citationsStatin effects on the incidence of major non-cardiovascular disease events among a global cohort of people with HIV: a randomised controlled trial.Marissa R Diggs, Triin Umbleja, Sara McCallum, Markella V Zanni, Sarah M Chu
The Lancet. HIV. 2025-04-01 - Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.Emma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, Carl J Fichtenbaum, Judith A Aberg
Open Forum Infectious Diseases. 2025-04-01
Press Mentions
Now Could Be the Best Time for Some to Get Fourth COVID-19 ShotFebruary 21st, 2022- What to Know About the Emergence of New COVID-19 VariantsFebruary 9th, 2022
- What Ohio’s Record-High COVID-19 Case Numbers Mean in Mid-JanuaryJanuary 18th, 2022
- Join now to see all
Committees
- Member, Multicenter AIDS Cohort Study (MACS) Cardiovascular Working Group 2017 - Present
- Member, ACTG End Organ Disease and Inflammation Transformative Science Group 2016 - Present
- Member, ACTG Underrepresented Populations Committee 2015 - 2016
Professional Memberships
- Member
- Member
- HIV Medical Association (HIVMA)Member
Other Languages
- Spanish, French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
